5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
Condition:   Tobacco Use Disorder Interventions:   Drug: Psilocybin;   Drug: Niacin Sponsors:   Johns Hopkins University;   University of Alabama at Birmingham;   New York University;   National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2022 Category: Research Source Type: clinical trials

Effect of Adjunctive Use of Vitamin B3 and B9 on Myeloperoxidase Level in the GCF of Patients With Stage I and II Periodontitis
Conditions:   Periodontitis Stage I;   Periodontal Diseases;   Periodontal Inflammation;   Periodontal Attachment Loss;   Periodontitis;   Periodontitis Stage II Interventions:   Drug: Vitamin B3 100 MG Oral Tablet;   Drug: vitamin B9;   Drug: Placebo;   Procedure: full mouth non surgical periodontal treatment Sponsor:   Cairo University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2022 Category: Research Source Type: clinical trials